St Vincent's Hospital, Sydney
St Vincent's Hospital, Sydney
Explore linked clinical trials.9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1 | Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, breast disorder, carcinoma, epithelial neoplasm, gynecomastia disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, skin disorder | Recruiting | Not applicable | 2026-04-27 | NCT07552922 | |
| Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma | Recruiting | Phase 1 | 2026-04-23 | NCT07203391 | |
| Bipolar Androgen Therapy + Carboplatin in mCRPC | Castration-resistant Prostate Cancer; Homologous Recombination Deficiency | Recruiting | Phase 2 | 2026-04-23 | NCT03522064 | |
| 10°C vs 4°C Lung Preservation RCT | Lung Transplant; Organ Preservation | Active, not recruiting | Not applicable | 2026-03-19 | NCT05898776 | |
| PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-03-03 | NCT05154162 | |
| Adding IL-2 to Tebentafusp to Eradicate Cancer Progression | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma | Recruiting | Phase 1 / Phase 2 | 2025-07-14 | NCT07063875 | |
| Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Active, not recruiting | Phase 1 | 2025-05-15 | NCT05156892 | |
| Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-05-15 | NCT04947189 | |
| The EXCEL Registry of Patients Requiring ECMO | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute respiratory failure, cardiac arrest, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2023-09-15 | NCT03793257 |